Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

Abstract

DM-ILD is more refractory to corticosteroid therapy, resulting in poorer prognosis compared with PM-ILD. These data indicate that intensive therapy, including cyclosporine, should be considered for DM-ILD.